Clinical Trial Update: Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device [NA]

View source ↗

Summary

Clinical trial update for Lavare Cycle in patients with HeartWare LVAD; study terminated with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hemolysis
• Stroke
• Thromboembolism

Drugs mentioned

• HeartWare Left Ventricular Assist Device
• Lavare Cycle

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Thromboembolism, Hemolysis | NA | Status: TERMINATED | Results posted: 2022-12-12